Personalized Care Act of 2023

Urged the Health Resources and Services Administration to extend the timeline for a request for information regarding a 340B Rebate Model Pilot Program. The current timeline does not permit sufficient time to gather information and provide complete answers, and instead suggested a deadline of April 30, 2026. (S.1562/H.R. 1197) - Preemie Reauthorization Act (S.2621/H.R. 1909) Preventing Maternal Deaths Reauthorization Act - Expressed support for enacting into law the Preemie Reauthorization Act and the Preventing Maternal Deaths Reauthorization Act. Both bills passed the House and Senate HELP Committee by near-unanimous votes during the 118th Congress. Both will expand research, education, and intervention activities related to preterm birth and strengthen federal support for Maternal Mortality Review Committees. Urged Congress to advise the administration to cancel the Health Resources and Services Administrations 340B Rebate Program, which threatens 340B hospitals ability to provide essential care and services to low-income rural patients (S.2372/H.R.4581) - 340B PATIENTS Act of 2025-Expressed support for the 340B Patients Act. This legislation would codify 340B providers' ability to use contract pharmacies to dispense 340B discounted drugs, ensure that 340B patients can pick up their prescriptions at any local pharmacy, and allow safety-net providers to continue providing expanded medical and social services to their communities using their 340B discount savings. (S. 2287/H.R. 4425) - Palliative Care and Hospice Education and Training Act (PCHETA) - Expressed support for the Palliative Care and Hospice Education and Training Act (PCHETA). This legislation would increase the number of permanent faculty in palliative care in medical schools, nursing schools, and other programs, promote education and research in palliative care and hospice, and support the development of faculty careers in academic palliative and hospice (S. 380) - Rural Obstetrics Readiness Act - Expressed support for the Rural Obstetrics Readiness Act. This bipartisan legislation would ensure that rural health care facilities are equipped with targeted resources to provide high-quality obstetric care to women within their own communities. (H.R. 1) - One Big Beautiful Bill Act - Urged CMS to implement the Medicaid provisions of (OBBBA) in ways that prevent eligible enrollees from losing coverage by maximizing data matching, preserving statutory exemptions, and avoiding unnecessary administrative burdens.

Client expense: $140,055 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), President of the U.S., SENATE

(S.1562/H.R. 1197) - Preemie Reauthorization Act (S.2621/H.R. 1909) Preventing Maternal Deaths Reauthorization Act - Expressed support for enacting into law the Preemie Reauthorization Act and the Preventing Maternal Deaths Reauthorization Act. Both bills passed the House and Senate HELP Committee by near-unanimous votes during the 118th Congress. Both will expand research, education, and intervention activities related to preterm birth and strengthen federal support for Maternal Mortality Review Committees. Urged Congress to advise the administration to cancel the Health Resources and Services Administrations 340B Rebate Program, which threatens 340B hospitals ability to provide essential care and services to low-income rural patients (S.2372/H.R.4581) - 340B PATIENTS Act of 2025-Expressed support for the 340B Patients Act. This legislation would codify 340B providers' ability to use contract pharmacies to dispense 340B discounted drugs, ensure that 340B patients can pick up their prescriptions at any local pharmacy, and allow safety-net providers to continue providing expanded medical and social services to their communities using their 340B discount savings. (S. 2287/H.R. 4425) - Palliative Care and Hospice Education and Training Act (PCHETA) - Expressed support for the Palliative Care and Hospice Education and Training Act (PCHETA). This legislation would increase the number of permanent faculty in palliative care in medical schools, nursing schools, and other programs, promote education and research in palliative care and hospice, and support the development of faculty careers in academic palliative and hospice (S. 380) - Rural Obstetrics Readiness Act - Expressed support for the Rural Obstetrics Readiness Act. This bipartisan legislation would ensure that rural health care facilities are equipped with targeted resources to provide high-quality obstetric care to women within their own communities. (H.R. 1) - One Big Beautiful Bill Act - Urged CMS to implement the Medicaid provisions of (OBBBA) in ways that prevent eligible enrollees from losing coverage by maximizing data matching, preserving statutory exemptions, and avoiding unnecessary administrative burdens.

Client expense: $152,536 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), President of the U.S., SENATE

REINSTATEMENT OF RICHARDSON WAIVER: Since 1971, the Richardson Waiver has ensured that Health and Human Services rulemaking related to agency management, grants, benefits, contracts, and loans are subject to public notice and comment. This longstanding, bipartisan practice promotes transparency and allows for meaningful stakeholder input in health care policymaking. Earlier this year, HHS announced it would reverse this precedent, ending its practice of soliciting public comments on the full array of proposed rules. In contrast to the transparency that this Administration has promised, this shift undermines the inclusive, evidence-based feedback process that is essential to sound health policy. In response, organizations are signing on in support of this Congressional Review Act resolution to reinstate the Richardson Waiver, put forward by Senators King and Wyden. Sent to Senate. PREEMIE ACT (H.R. 1197) AND PREVENTING MATERNAL DEATHS ACT (S.2621/H.R.1909): Letter to Congress strongly urging passage of the PREEMIE ACT AND PREVENTING MATERNAL DEATHS ACT to reauthorize and expand research, education and intervention activities related to preterm birth, along the Preventing Maternal Deaths Reauthorization Act (PMDA) which would strengthen federal support for Maternal Mortality Review Committees (MMRCs). Both of these bills passed the House and Senate HELP Committee by near unanimous votes during the 118th Congress. The U.S. has one of the highest maternal mortality and morbidity rates in the developed world. HEALTHY START REAUTHORIZATION ACT (H.R. 3302) - INTERFAITH STATEMENT (Sent to Congress): Healthy Start-the USAs only federally funded, community-driven program solely focused on reducing infant mortality-is under immediate threat. Last week, the Administration terminated the entire staff of the Division of Healthy Start and Perinatal Services (DHSPS) within the U.S. Department of Health and Human Services. This action effectively dismantles the federal infrastructure that supports Healthy Start, undermining decades of progress in maternal and infant health-at a time when infant mortality is rising, with Mississippi declaring a public health emergency due to a sharp increase in infant deaths. The statement signed by interfaith advocacy groups calls for the reversal of these terminations, full funding for Healthy Start, and swift passage of the Healthy Start Reauthorization Act (H.R. 3302). IMPACTS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) DECISION ON HEPATITIS B - BIRTH DOSE: Letter endorsing Reps. Chu and Schrier's letter to the Government Accountability Office (GAO) requesting that they examine the projected public-health, economic, and equity impacts if the Centers for Disease Control (CDC) were to adopt ACIPs decision to not recommend the Hepatitis B vaccine at birth to all infants.

Client expense: Not reported · Firm income: $20,000

Government targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, President of the U.S., SENATE